Sun, Sep 21, 2014, 12:41 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • rynotheknife rynotheknife Jan 30, 2013 7:13 AM Flag

    2013 guidance seems very modest

    1,200M sales... 700 Incivek, 300 Kaly, 125 Royalties, & 75 Collab Rev

    100 Prod Cost of Sales + 1,100 Non-GAAP Exp (750 R&D & 350 SG&A) = 1,200M Total Costs/Exp

    So 2013 guidance is non-GAAP break-even which = a GAAP loss of ~$250M

    Very curious how this trades today... BOL

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • even a person like me (1/2 empty glass) sees hope and improvement in VRTX. Need that one good clinical trial and this thing pops 20 bucks in one day. Not sure when the next trial will read out but it's later this summer or so I think. Anyway, 11.4K PM volume with little price movement. Depends on the big boys and what they say. Remember, GS last Q said 42 target and dump from 50 and it hit 38's. I looked and didn't see any analyst action so far (730am time). It's not bad. Didn't listent to the call so not sure how the CEO did but my guess is he's upbeat and in wait and see mode in what vrtx can do for medicine and shareholders. I'm hoping some see the light and upgrade or start buying towards the climb to 60.

 
VRTX
103.75+6.40(+6.57%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Genworth Financial, Inc.
NYSEFri, Sep 19, 2014 4:03 PM EDT
Continental Resources, Inc.
NYSEFri, Sep 19, 2014 4:07 PM EDT
First Majestic Silver Corp.
NYSEFri, Sep 19, 2014 4:02 PM EDT